Share Prices & Company Research

Market News

30 Jun 2020 | 16:22

Immunodiagnostic Systems starts sale of Covid antibody test

(Sharecast News) - Laboratory diagnostic services provider Immunodiagnostic Systems announced on Tuesday that its "fully automated" SARS-CoV-2 (Covid-19) IgG antibody test was available for sale. The AIM-traded firm said the test could now be purchased by customers in the UK, the European Union, and a number of other countries which accept the CE-mark as the basis of regulatory approval.

It said it had started the process of working with a number of national reference centers and governmental bodies, to ensure a roll-out according to national guidelines.

"We are pleased to announce the release to the market of our automated SARS -CoV-2 antibody test, running on the IDS-iSYS analyser," said chief executive officer Jaap Stuut.

"Immunodiagnostic Systems will now seek to commercialise this test via our direct sales force in Europe, and through our extensive distribution network elsewhere, and we look forward to joining the efforts to minimise the impact of the Covid-19 virus."

At 1534 BST, shares in Immunodiagnostic Systems were up 10% at 264p.
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 10th July 2020
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.